ARCHIVES

In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982

This article is from The Cancer Letter archive.

Vol. 08 No. 24 | June 11, 1982

Download PDF Visit The Full Archive

Related Articles

Funding Opportunity: Defense Department Offering $30.5 Mil In Research Grants

April 18, 2014

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

January 8, 1993

ASCO Expanding Tools To Improve Coordination Of Cancer Treatment

November 30, 2007

FDA Committee nixes Combination Guidelines, Okays New NDA Policy

January 21, 1977

Group Sets Prostate Research Agenda; Strategy, Funding Demands to Follow

November 8, 1996

HHS Forms Office for Recovery Act

March 13, 2009